Type 1 diabetes mellitus with other diabetic neurological complication
ICD-10 E10.49 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with other diabetic neurological complication.
Type 1 diabetes mellitus is characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Patients with this condition often experience various complications, including diabetic neuropathy, which can manifest as peripheral neuropathy, autonomic neuropathy, or focal neuropathies. The term 'other diabetic neurological complication' encompasses a range of neurological issues that may arise due to chronic hyperglycemia and metabolic derangements associated with diabetes. These complications can significantly impact a patient's quality of life and may include symptoms such as pain, numbness, tingling, and weakness in the extremities. Management of type 1 diabetes involves careful monitoring of blood glucose levels, with an emphasis on maintaining HbA1c levels below 7% to reduce the risk of complications. Insulin therapy is the cornerstone of treatment, requiring individualized regimens that may include multiple daily injections or continuous subcutaneous insulin infusion. Regular follow-up and comprehensive care are essential to address both glycemic control and the management of neurological complications.
Detailed records of blood glucose levels, HbA1c results, and treatment plans.
Patients presenting with uncontrolled diabetes and neurological symptoms.
Endocrinologists must ensure comprehensive documentation of both diabetes management and neurological assessments.
Thorough neurological examinations and symptom descriptions.
Patients with diabetes presenting with neuropathic pain or other neurological deficits.
Neurologists should document the relationship between diabetes and neurological findings to support coding.
Used for follow-up visits for diabetes management and assessment of neurological symptoms.
Document patient's diabetes management, HbA1c levels, and neurological assessments.
Endocrinologists and neurologists should ensure comprehensive documentation to support the visit level.
Common neurological complications include diabetic peripheral neuropathy, autonomic neuropathy, and focal neuropathies, which can lead to symptoms such as pain, numbness, and weakness.
E10.49 is used for type 1 diabetes with other specified neurological complications, while E10.40 is specifically for diabetic neuropathy without further specification.
